Fagron NV (OTCMKTS:ARSUF – Get Free Report) was the recipient of a significant decline in short interest during the month of April. As of April 30th, there was short interest totaling 41 shares, a decline of 99.8% from the April 15th total of 20,181 shares. Based on an average trading volume of 1 shares, the days-to-cover ratio is presently 41.0 days.
Fagron Stock Performance
Shares of OTCMKTS:ARSUF remained flat at $26.53 on Monday. Fagron has a 12-month low of $26.00 and a 12-month high of $27.00. The business has a fifty day simple moving average of $26.81 and a 200 day simple moving average of $25.35.
About Fagron
Fagron (OTCMKTS:ARSUF) is a global pharmaceutical compounding company that supplies raw materials, equipment and services to compounding pharmacies, hospitals and healthcare practitioners. Its portfolio encompasses a range of pharmaceutical ingredients, dosage forms and specialized compounding solutions designed to meet patient-specific needs. The company supports the preparation of customized medications in areas such as dermatology, pain management, hormone replacement therapy and veterinary medicine, providing both sterile and non-sterile compounding products.
Headquartered in Rotterdam, the Netherlands, Fagron operates in more than 55 countries across Europe, the Americas, Asia-Pacific and the Middle East & Africa.
Read More
- Five stocks we like better than Fagron
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Fagron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fagron and related companies with MarketBeat.com's FREE daily email newsletter.
